期刊文献+

乌司他丁在原位肝移植术中对脏器的保护作用 被引量:2

下载PDF
导出
摘要 原位肝移植及其引发的病理过程可以对肌体脏器产生不同程度的损害,而有效的药物应用会降低各主要脏器的损害程度。乌司他丁是从健康成年男性尿液中分离纯化出来的一种胰蛋白酶抑制剂,无免疫原性,具有广谱、高效的蛋白酶抑制活性,并能够稳定溶酶体膜,清除氧自由基及抑制炎性介质释放和过度炎性反应,改善微循环,对全身各主要脏器产生保护作用。本文主要介绍乌司他丁在原位肝移植手术中对供肝、移植肝、肝移植患者肺、肾脏以及血液系统的保护作用及其机制。
作者 彭龙希
出处 《天津药学》 2015年第6期62-64,共3页 Tianjin Pharmacy
  • 相关文献

参考文献25

  • 1叶明,郑俊波,于凯江,姜雪松,周晶.大剂量乌司他丁治疗甲型H1N1流感所致重症肺炎的疗效观察[J].中国危重病急救医学,2011,23(1):48-49. 被引量:12
  • 2Song J, Park J, Kim J Y,et al. Effect of Ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: A randomized doubleblinded study[J]. Korean J Anesthesiol,2013, 64(4) :334 -340.
  • 3Leng Y X,Yang S G,Song Y H,et al. Ulinastatin for acute lung inhury and acute respiratory distress syndrome: A systematic review and meta - analysis [J]. World J C fit Care Med,2014,3 ( 1 ) : 34 - 41.
  • 4崔瀚文,袁清,洪善娟,韦星,许亮,黄海燕,王全兴,蔡明.乌司他丁对脂多糖介导的小鼠肾脏固有树突状细胞成熟的抑制作用[J].中华器官移植杂志,2013,34(4):244-247. 被引量:1
  • 5Abraham P, Rodriques J, Moulick N, et al. Efficacy and safety of intravenous Ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis[J]. J Assoc Physicians India,2013,61 ( 8 ) :535 - 538.
  • 6洪勇,古维立,曹杰,夏杰.乌司他丁对肝脏冷保存损伤的保护作用研究[J].中国危重病急救医学,2007,19(7):398-400. 被引量:4
  • 7江翰,王子豪,李永盛,边睿,施伟斌.乌司他丁对大鼠原位肝脏移植供肝的保护作用[J].中国普通外科杂志,2014,23(1):53-57. 被引量:7
  • 8Karnad D R, Bhadade R, Verma P K, et al. Intravenous administration of Ulinastatin (human urinary trypsin inhibitor in severe sepsis: A multicenter randomized controlled study [J]. Intensive Care Med, 2014,40 (6) :830 -838.
  • 9Zhang L, Wang N, Zhou S, et al. Preventive effect of Ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients[J]. World J Surg Oncol,2013,11:84.
  • 10Yukihiro O, Masayuki S,Takao H,et al. Protective effects of ulinastatin against ischemia - reperfusion injury [J]. J Surg Res, 1999,82 : 34 - 42.

二级参考文献133

共引文献93

同被引文献26

  • 1张炳东,秦科,黄海清,肖志凌,陈晓莉,梁东科.乌司他丁对瓣膜置换术患者心肌炎性反应的影响[J].中国体外循环杂志,2006,4(1):18-22. 被引量:8
  • 2林洪远,管向东,周立新,艾宇航,王可富.乌司他丁、α1胸腺肽联合治疗严重脓毒症——一种新的免疫调理治疗方法的临床研究[J].中华医学杂志,2007,87(7):451-457. 被引量:100
  • 3Caforio A L,Tona F,Bottaro S,et al.Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy[J].Autoimmunity,2009,42(41):35-45.
  • 4Towbin J A,Lowe A M,Colan S D,et al.Incidence,causes,and outcomes of dilated cardiomyopathy in children[J].Jama the Journal of the American Medical Association,2006,296(15):1867-1876.
  • 5Kindermaim I,Barth C,Mahfoud F,et al.Update on myocarditis[J].J Am Coll Cardiol,2012,59(2):779-792.
  • 6Brunetti L,Desantis E R.Treatment of viral myocarditis caused by coxsackievirus B[J].American journal of health-system pharmacy,2008,65(2):132-137.
  • 7Kuhl U,Pauschinger M,Schwimmbeck P L,et al.Interferon-Ptreatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction[J].Circulation,2003,107(12):2793-2798.
  • 8Daliento L,Calabrese F,Tona F,et al.Successful treatment of enterovirus-induced myocarditis with interferon-a[J].Journal of Heart&Lung Transplantation the Official Publication of the International Society for Heart Transplantation,2003,22(2):214-217.
  • 9Tunkel H A.Treatment of potentially life-threating enterovirus infections with pleconari[J].Clinical Infectious Diseases an Official Publication of the Infectious Diseases Society of America,2001,32(4):228-235.
  • 10Mason J W,Herskowitz A,Rose N R,et al.A clinical trial of immunosuppressive therapy for myocarditis[J].New England Journal of Medicine,1995,333(12):269-275.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部